Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs

Overview of attention for article published in Journal of Controlled Release, March 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 7,237 followers.

Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs. | Steve R Roffler, Kaohsiung Medical Univ. | #prodrug #immunoenzyme https://t.co/Maifzx3sIR https://t.co/tUCFmZeNmx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.